Structure Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GPCR and other ETFs, options, and stocks.

About GPCR

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. 

CEO
Raymond C. Stevens
CEORaymond C. Stevens
Employees
163
Employees163
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2016
Founded2016
Employees
163
Employees163

GPCR Key Statistics

Market cap
6.16B
Market cap6.16B
Price-Earnings ratio
-23.86
Price-Earnings ratio-23.86
Dividend yield
Dividend yield
Average volume
1.11M
Average volume1.11M
High today
$90.40
High today$90.40
Low today
$86.10
Low today$86.10
Open price
$88.48
Open price$88.48
Volume
741.79K
Volume741.79K
52 Week high
$94.90
52 Week high$94.90
52 Week low
$13.22
52 Week low$13.22

Analyst ratings

100%

of 16 ratings
Buy
100%
Hold
0%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.